Abstract
OBJECTIVE: To achieve consensus on a definition of remission in SLE (DORIS).
BACKGROUND: Remission is the stated goal for both patient and caregiver, but consensus on a definition of remission has been lacking. Previously, an international task force consisting of patient representatives and medical specialists published a framework for such a definition, without reaching a final recommendation.
METHODS: Several systematic literature reviews were performed and specific research questions examined in suitably chosen data sets. The findings were discussed, reformulated as recommendations and voted on.
RESULTS: Based on data from the literature and several SLE-specific data sets, a set of recommendations was endorsed. Ultimately, the DORIS Task Force recommended a single definition of remission in SLE, based on clinical systemic lupus erythematosus disease activitiy index (SLEDAI)=0, Evaluator's Global Assessment <0.5 (0-3), prednisolone 5 mg/day or less, and stable antimalarials, immunosuppressives, and biologics.
CONCLUSION: The 2021 DORIS definition of remission in SLE is recommended for use in clinical care, education, and research including clinical trials and observational studies.
| Originalsprog | Engelsk |
|---|---|
| Artikelnummer | e000538 |
| Tidsskrift | Lupus science & medicine |
| Vol/bind | 8 |
| Udgave nummer | 1 |
| ISSN | 2053-8790 |
| DOI | |
| Status | Udgivet - nov. 2021 |
Fingeraftryk
Dyk ned i forskningsemnerne om '2021 DORIS definition of remission in SLE: final recommendations from an international task force'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS